This page contains potentially life-saving, life-extending information. It’s important you know about the 2 very different types of immunotherapy – one type is cell-based (made from your own cells) & the other is drug-based.
NOTE: While you will not find this information in our hospitals; you will find it in many credible medical journals.
Our advice; spend generous time on this page to boost your cancer health literacy and thus – boost your survival odds.
But first – in order to better understand more about the efficacy & and safety of cell-based immunotherapy; a basic understanding of what causes cancer is essential.
Cancer is a disease resulting from damage or changes to your genes. We each have about 24,000 genes.
Since cancer is a disease of damaged genes; the next section reveals something rarely seen in cancer medicine before.
Can cell-based immunotherapy repair damaged DNA responsible for driving your cancer?
With cell-based immunotherapy you can recharge, repair & rebuild your immune system…
For 5 years, we’ve referred patients to the world pioneer of cell-based immune therapies in Asia. Our patients experience outcomes consistently beyond clinical expectations. As well; these minimally invasive treatments are safe & predictable.
For example; the genomic tests (we use in Australia) typically reveal a patient’s mutated or deleted DNA. As the pictures above indicate; damaged genes can be causes or drivers of their cancer.
We have observed that cell-based immunotherapy (Japan) may help to normalise DNA homeostasis. This has been evidenced by continual monitoring and follow up of patients via genomic testing.
In some patients it appears that repair of DNA mutations is occurring.
We will be researching this surprising effect further in 2019.
Our Global Immune Specialist:
The immune specialist to whom we refer our navigated patients, a highly acclaimed MD PhD; has been called the Father of Immunotherapy in Asia. He and his colleagues pioneered unique, personalised cancer vaccines to deliver, safe and effective cancer treatment to significantly contribute to patients’ life extension.
They invented a novel (patented) in vitro cell expansion system for obtaining a large number of highly activated human NK cells and T cells that can now be used for cancer immunotherapy.
Over many decades, there have been several reports from various countries on successful application of cell-based immunotherapy to various solid tumours and haematological malignancies.
Our immunotherapy colleague believes that cancer has to be tackled by multi-disciplinary approaches.
More Good News: Combining cell-based immunotherapy using NK cells and CTL (cytotoxic lymphocytes) with hyperthermia & low-dose chemotherapy, can for some patients, be a very effective strategy to treat cancer.
Of most importance; cell-based immunotherapy can be of great value to prevent cancer recurrence.
Our immunotherapy colleague in Asia believes that many cancers have to be tackled by multi-disciplinary approaches, especially when there is high tumour volume.
Why is chemotherapy used sometimes? Doesn’t it destroy the immune system?
Don’t’ throw the baby out with the bathwater – chemotherapy can be immune stimulating. Read on!
Our Immunotherapy expert in Asia says that sometimes low dose chemotherapy & immunotherapy can be synergistic and help to orchestrate immune function. There is growing body of literature on chemotherapy-induced anti-tumour immunomodulation.
No guess work – no more one size fits all
During the course of their stay in Asia (usually 3 weeks); our immunotherapy colleague provides our clients with a series of specific immune function reports.
These include measurements of immune cells: quantity of cells, functionality and percentages of cells before during and after treatment.
As well, blood is measured using sophisticated cancer markers and tests not used in conventional Western cancer medicine.
To enhance your immune activities he can use many types of immune cells such as NK cells, NKT cells, γδT cells, αβT cells, cytotoxic T cells (CTL) and dendritic cells (DC). In the multidisciplinary approach to treating cancer, many different types of cells can be used.
Why our immunotherapy colleague focuses on enhancing NK cell function.
1. – the epidemiological data show the relationship between NK activity and cancer incidence.
2. – they can measure NK cell number and activity in patient’s blood to monitor the immune status of patients to evaluate the effect of treatment
3. – experimental results show that expanded NK cells can kill cancers efficiently.
4. – in patients with cancer and viral infection, NK cells function has been shown to be impaired. Our colleague has also shown that NK activity in peripheral blood was significantly lower with breast cancer than that of healthy individuals. Data suggests the important role of NK cells for host defence mechanisms against cancer.
5. – NK cells can enhance the effects of monoclonal antibody (mAb) treatments on cancers through antibody-dependent cellular cytotoxicity (ADCC).
picture left: Natural killer (NK) cells (white) attack a cancer cell (purple)
Cell based Immune therapies may hold the answer to your cancer. Please view the videos below to witness the miracle within – our immune system.
Addressing a commonly asked Question:
Perhaps you have been thinking, ‘please explain more about the difference between the cell-based immune therapies discussed on this page and the drug-based immune therapies promoted widely in the media and now being enthusiastically adopted in our cancer hospitals. (AU & NZ) “
Differences between drug based and cell based immune therapies
Drug based immune therapies:
- mass produced by big pharma companies
- sold globally – very expensive
- occasional excellent outcomes in some cancers, but still considered experimental – although FDA approved.
- side effects – highly unpredictable – ranging from mild to severe; some fatal (heart attack etc)
- now being used in trials for other cancers
- some long term side effects in survivors are known but many are still unknown
- click here for references outlining the unpredictability and dangers of the drug-based immune therapies
- View lawsuits re drug-based immune therapies
Blood or blood tissue (cell) based immune therapies:
- personalised from your cells – one patient – one doctor – low profit margins – big pharma can’t profit from this
- consistent exceptional patient outcomes
- side effects – minimal – predictable – most patients experience no side effects
- not experimental – our collegiate clinic has treated 10-15,000 patients since 1990 – prolific medical Journal publications
- value add – can safely enhance other treatments, e.g. low dose chemotherapy, hypothermia, cyber knife, proton beam therapy and stereo tactic radiation
- long term effects known – no negative outcomes observed.